Your browser doesn't support javascript.
loading
Assessing the Added Therapeutic Benefit of Ultra-Expensive Drugs.
DiStefano, Michael J; Kang, So-Yeon; Yehia, Farah; Morales, Christian; Anderson, Gerard F.
  • DiStefano MJ; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA. Electronic address: mjad88@gmail.com.
  • Kang SY; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Yehia F; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Morales C; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA.
  • Anderson GF; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Value Health ; 24(3): 397-403, 2021 03.
Article en En | MEDLINE | ID: mdl-33641774
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Medicare Part D / Medicamentos bajo Prescripción Tipo de estudio: Health_technology_assessment Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Análisis Costo-Beneficio / Medicare Part D / Medicamentos bajo Prescripción Tipo de estudio: Health_technology_assessment Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article